Thursday, July 19, 2018

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Partners with Ohio State University to Develop Shelf-stable Liquid Food and Beverage Products


Global life sciences company Pressure BioSciences (OTCQB: PBIO) this morning announced a collaboration with The Ohio State University’s College of Food, Agricultural, and Environmental Sciences (“CFAES”). The collaborative project seeks to develop and commercialize a continuous-flow manufacturing technology to prepare liquid foods and beverages with preservation of superior sensory and nutritional qualities, while also providing an extended shelf life without refrigeration or chemical additives. Pressure BioSciences believes that, through scale-up of its innovative and patented Ultra Shear Technology (“UST”), the delivery of higher quality, longer lasting liquid foods and beverages is possible. The collaborative project is supported by a four-year, $891,000 grant awarded to CFAES scientists by the U.S. Department of Agriculture’s National Institute of Food and Agriculture (“NIFA”). PBIO has been granted a $318,000 sub-contract by Ohio State to build a working benchtop instrument and a pilot plant floor model UST machine. The company has commenced work on this project. “The ultimate goal of this collaborative project is for consumers to benefit from the increased availability of wholesome, healthy, better-tasting, shelf-stable, clean label liquid food and beverage options. Imagine liquid foods like milk shipped and stored at room temperature for extended periods of time post-processing, while retaining superior nutritional and taste qualities. The advantages and cost-savings to the consumer and dairy industry could be game-changing. The advantages and cost savings to schools, the military, disaster relief agencies, and other such groups could be equally significant. This technology development is very exciting, and potentially very rewarding, for all stakeholders in PBI,” Pressure BioSciences president and CEO Richard T. Schumacher stated in the news release.

To view the full press release, visit http://ibn.fm/9Utsa

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html